Request a representative visit or G7 15 Day or G7 samples
CSS Do not remove
G7 15 Day: A win for adults with any type of diabetes
Adult patients with diabetes patient profiles
Meet William, 40*
Monitoring glucose levels will help William make informed decisions in the moment to better his glucose control. He is motivated to avoid mealtime insulin.
- Type 2 diabetes for 8 years
- A1C 8.7%, BMI 35, history of cardiovascular disease and previous MI
- Diabetes medications
- Empagliflozin 25 mg once daily
- Degludec 45 units once daily
- Semaglutide 2.0 mg once weekly
- Metformin 1000 mg twice daily
*Hypothetical patient case.
Guidelines recommend CGM for adult patients with type 2 diabetes who use insulin.1
- ADA also encourages consideration for patients with type 2 diabetes who do not use insulin1
Meet Margaret, 68*
Margaret struggles to lower her A1C despite blood glucose logs that are mostly in range. She recently had two severe hypoglycemic events. She wants to avoid increasing her insulin dosage due to fear of going low.
- Type 2 diabetes for 19 years
- A1C 8.3%
- Diabetes medications
- 15 units of glargine once daily
- 4 units of aspart with breakfast and lunch, and 5 units at dinner
- Intolerant of other medications
*Hypothetical patient case.
ADA guidelines encourage CGM for all adult patients with type 2 diabetes.1
- ADA also encourages consideration for patients with type 2 diabetes who do not use insulin1
Coverage & Affordability
Extensive coverage through a broad range of commercial and Medicare plans*
Ready to Prescribe?
Get your patients started with Dexcom G7 15 Day CGM
A1C=hemoglobin A1C; ADA=American Diabetes Association; BMI=body mass index; CGM=continuous glucose monitoring; CPT=Current Procedural Terminology; DME=durable medical equipment; MI=myocardial infarction.
†Individual plan pricing may vary depending on insurance coverage. Under Medicare’s DME schedule, reimbursement and coinsurance for CGMs using CPT codes A4239 and E2103 are the same regardless of CGM brand.
1 American Diabetes Association PPC. Diabetes Care—2025. Diabetes Care. 2025;48(Suppl. 1):S146-S166.
MAT-11250